Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Daiichi Sankyo
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologically or cytologically confirmed metastatic (stage IV) NSCLC with no significant pleural effusion or pleural involvement from the tumor
Age greater than or equal to 18 years
Adequate organ and bone marrow function
You may not be if
Any prior systemic therapy for NSCLC
Major surgical procedure or other investigational agents within 4 weeks before study enrollment
Need for concomitant use of other thiazolidinediones during the study
History of any of the following conditions within 6 months prior to initiating study treatment: Diabetes mellitus requiring treatment with insulin or sulfonylureas or thiazolidinediones (TZDs) agents; Myocardia infarction with significant impairment of cardia function; Malabsorption syndrome, chronic diarrhea, inflammatory bowel disease or partial bowel obstruction;
Clinically active brain metastases, uncontrolled seizure disorder; spinal cord compression or carcinomatous meningitis
